Research presented at the 2015 Annual Meeting of The North American Menopause Society (NAMS) supports previous findings that use of local estrogens for genitourinary symptoms of menopause (vaginal dryness, painful intercourse, and urinary tract infections) are underutilized, but the study also reports that method of local treatment can impact treatment duration and adherence to therapeutic guidelines.
The study authors analyzed data on 21,400 women and their preferred method of treatment and length of treatment over a nine-year period. Overall 82% were sporadic users (no more than four total prescriptions utilized) and 60% remained with one therapy over time. A total of 79% of the women used a cream treatment, yet those using vaginal tablets were more likely to adhere to the suggested regimen for a longer period of time (1,002 days vs. 787 days).
“Since both treatment options are comparable in the results they produce, this study sends a strong message to physicians to consider an alternative treatment method that women prefer and might follow longer,” said lead author Israel Yoles. “While cream is more commonly prescribed, the end results are likely to be better with tablets because they are more often being taken as directed.”
For more information visit Menopause.org.